Revolution Medicines, Inc. revenue

Revolution Medicines, Inc.'s revenue was $0 in fiscal 2025.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Revolution Medicines, Inc.: revenue history, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	20	50	43	29	35	12	0	0
Growth on the year before	—	+148.2%	−14.1%	−31.6%	+20.4%	−67.3%	−100.0%	—

US$ thousands unless shown otherwise. Fiscal quarters.

Revolution Medicines, Inc.: revenue history, quarterly
Quarter	2023 Q1Mar 2023	2023 Q2Jun 2023	2023 Q3Sept 2023	2023 Q4Dec 2023	2024 Q1Mar 2024	2024 Q2Jun 2024	2024 Q3Sept 2024	2024 Q4Dec 2024
Revenue	7,014	3,824	0	742	0	0	0	0
Growth on the same quarter a year before	—	—	—	—	−100.0%	−100.0%	—	−100.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Revolution Medicines, Inc.